Use of MUAC as Basic Criterion for Admission, Follow-up and Exit From the Ambulatory Nutrition Program

NCT03280082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6200

Last updated 2021-02-10

No results posted yet for this study

Summary

The aim of this study is to provide comprehensive documentation of the relevant results and operational implications of this new model using Mid-Upper Arm Circumference (MUAC) as the single anthropometric criterion for admission, monitoring and exit of non- complicated in Niger.

Conditions

  • Malnutrition

Interventions

OTHER

MUAC Program

All children admitted to the PB program will receive standard care according to the national Protocol and that of MSF, including preventive and therapeutic care at admission as well as hospital care in case of clinical complications. There will be no change in the Protocol for the hospital care to the CRENI (Center of Intensive Nutritional Rehabilitation). RUTF (Ready-to-Use therapeutic food) will be distributed on a weekly basis according to the dosage of RUTF in the national protocol.

OTHER

Standard Program

All children admitted to the standard program will receive standard care according to national and MSF protocols, including preventive and therapeutic care on admission as well as hospital care in case of clinical complications. RUTF will be distributed on a weekly basis according to the dosage of RUTF in the national protocol.

Sponsors & Collaborators

  • Medecins Sans Frontieres, Spain

    collaborator OTHER
  • Direction de la Nutrition du Niger

    collaborator UNKNOWN
  • District Sanitaire de Madaoua, Niger

    collaborator UNKNOWN
  • Direction Régionale Sanitaire de Tahoua, Niger

    collaborator UNKNOWN
  • Epicentre

    lead OTHER

Principal Investigators

  • Rebecca GRAIS, PhD · Epicentre

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-25
Primary Completion
2019-02-28
Completion
2020-12-31

Countries

  • Niger

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03280082 on ClinicalTrials.gov